Proposals for a new therapeutic strategy for simple Plasmodium falciparum malaria attacks in Cameroon

Trop Med Parasitol. 1992 Jun;43(2):118-20.

Abstract

From simplified in vivo tests, authors set up a cartography of the sensitivity of Plasmodium falciparum to amino-4-quinolines in Cameroon; they also evaluated the clinical and parasitological efficacy of different therapeutic protocols which make use of amino-4-quinolines, quinine, mefloquine and halofantrine. All these drugs are administered orally. They recommend maintaining home medication with chloroquine at the dose of 25 mg/kg over 3 days, conserving quinine for use in the case of a possible failure. The use of most recent antimalarials can be proposed only as a last resort.

MeSH terms

  • Administration, Oral
  • Aminoquinolines / administration & dosage
  • Aminoquinolines / pharmacology
  • Aminoquinolines / therapeutic use*
  • Amodiaquine / administration & dosage
  • Amodiaquine / pharmacology
  • Amodiaquine / therapeutic use
  • Animals
  • Antimalarials / administration & dosage
  • Antimalarials / pharmacology
  • Antimalarials / therapeutic use*
  • Cameroon
  • Child
  • Child, Preschool
  • Chloroquine / administration & dosage
  • Chloroquine / pharmacology
  • Chloroquine / therapeutic use
  • Drug Resistance
  • Humans
  • Malaria, Falciparum / drug therapy*
  • Mefloquine / administration & dosage
  • Mefloquine / pharmacology
  • Mefloquine / therapeutic use
  • Phenanthrenes / administration & dosage
  • Phenanthrenes / pharmacology
  • Phenanthrenes / therapeutic use
  • Plasmodium falciparum / drug effects*
  • Quinine / administration & dosage
  • Quinine / pharmacology
  • Quinine / therapeutic use

Substances

  • Aminoquinolines
  • Antimalarials
  • Phenanthrenes
  • Amodiaquine
  • Chloroquine
  • Quinine
  • halofantrine
  • Mefloquine